alexa Editor - Wen-Hai Shao | Temple University | 19049

Journal of Molecular Immunology
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Wen-Hai Shao

Wen-Hai Shao
Wen Hai Shao
Section of Rheumatology
Department of Medicine
Temple University
USA
Temple University

Biography

Dr. Shao received his MS at Wuhan Institute of Virology (WIV), Chinese Academy of Sciences. He then moved to University of Louisville in Kentucky, USA, where he graduated with a Ph.D. in immunology. Dr. Shao started his postdoc research at the University of Pennsylvania under Dr. Philip Cohen in the area of autoimmunity. Dr. Shao moved to Temple University in 2008 and continued his research studying the molecular basis and pathogenesis of lupus and lupus nephritis using TAM- (Tyro3, Axl, Mer) deficient mice. He was appointed the Assistant Professor of Medicine in 2010.

Research Interest

MY research interest is to elucidate the mechanisms that underlie the regulation of autoimmune responses and the homeostatic control of inflammation. I have discovered that the Mer receptor tyrosine kinase mediates renal protection in nephrotoxic serum-induced glomerulonephritis. I am currently unraveling the molecular and cellular determinants that account for the TAM-kinase (Tyro3, Axl, Mer) mediated regulation of renal inflammation. Recently, we found that Stat1 deficient mice develop strikingly prolonged, severe autoimmune disease when used as host in Bm12-to-B6 chronic graft-versus-host disease cGVHD, with increased autoantibody production and severe nephritis. I am exploring the aberrant signaling brought about by the absence of Stat1 to deduce its importance as a key regulator in autoimmune renal inflammation.

Certificate

Certificate

Global Speakers in the subject

Global Experts in the subject

Leave Your Message 24x7
Top